福永 興壱

Medicine & Life Sciences

1. Coronavirus 100%
2. Asthma 72%
3. Japan 54%
4. Lung 52%
5. Chronic Obstructive Pulmonary Disease 37%
6. Eosinophils 32%
7. SARS Virus 31%
8. Pneumonia 31%
9. Inflammation 28%
10. Non-Small Cell Lung Carcinoma 28%
11. Mycobacterium avium Complex 27%
12. Advisory Committees 25%
13. Tomography 25%
14. Standing Position 24%
15. Lung Neoplasms 23%
16. Adrenal Cortex Hormones 23%
17. Lung Diseases 22%
18. Respiratory Function Tests 22%
19. Supine Position 21%
20. Severe Acute Respiratory Syndrome 21%
21. Therapeutics 20%
22. Acute Lung Injury 17%
23. Adenocarcinoma of Lung 16%
24. dupilumab 16%
25. Bronchoalveolar Lavage Fluid 15%
26. Tobacco Products 15%
27. Serum 14%
28. Neutralizing Antibodies 14%
29. Smoke 14%
30. Infections 14%
31. Obstructive Sleep Apnea 13%
32. Allergic Bronchopulmonary Aspergillosis 13%
33. Phenotype 13%
34. Platelet Activating Factor 13%
35. presqualene pyrophosphate 13%
36. Alveolar Epithelial Cells 13%
37. Lymphocytes 13%
38. Cohort Studies 12%
39. Retrospective Studies 12%
40. cysteinyl-leukotriene 11%
41. Multicenter Studies 11%
42. Cyclooxygenase 2 11%
43. prostaglandin D2 receptor 11%
44. Smartphone 11%
45. 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid 11%
46. Cytokines 10%
47. Ovalbumin 10%
48. lipoxin A4 10%
49. pranlukast 10%
50. Steroids 10%